Suppression of HIV replication in vitro by CD8+ T-cells from HIV-infected and HIV-seronegative individuals

International Journal of STD and AIDS

Volumn 8, Issue 5, 1997, Pages 307-310

  Tsuchie, H ^a   Detorio, M A ^a,b   Hossain, M M ^a   Tesfamariam, N ^c   Trickett, A ^c   Lam Po Tang, P R ^c   Yamada, O ^a   Ichimura, H ^d   Dwyer, J M ^c   Kurimura, T ^a  

^a OSAKA UNIVERSITY   (Japan)

^b Japan Chem Res Pharmaceut Co L   (Japan)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

CD8+ T cells; Cytokine; HIV

Indexed keywords

CD8 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS INHIBITION; VIRUS REPLICATION;

CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV SERONEGATIVITY; HIV-1; HUMANS; VIRUS REPLICATION;

EID: 8244258024     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462971920145     Document Type: Article

References (19)

1. Fauci AS. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 1988;239:617-22
2. Weiss RA, Clapham PR, Weber JN, et al. Variable and conserved neutralization antigens of human immunodeficiency virus. Nature 1986;324:572-5
3. Blummberg RS, Paradis T, Hartshorn KL, et al. Antibody-dependent cell-mediated cytotoxicity against cells infected with the human immunodeficiency virus. J Infect Dis 1987;165:878-84
4. Walker BD, Chakrabarti S, Moss B, et al. HIV-specific cytotoxic T-lymphocytes in seropositive individuals. Nature 1987;328:345-8
5. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986;234:1563-6
6. + T-cells inhibit HIV replication in naturally infected T-cells. Evidence for a soluble factor. J Immunol 1990;144:2961-6
7. + cell anti-HIV activity: nonlytic suppression of virus replication. AIDS Res Hum Retrovir 1992;6:1039-50
8. + T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism. AIDS Res Hum Retrovir 1993;9:1079-86
9. + T-cells derived from nonhuman primates. Clin Exp Immunol 1993;91:473-81
10. François C-H, Aunis D, Schaeffer E. Interactions of the transcription factor AP-1 with the long terminal repeat of different human immunodeficiency virus type 1 strains in Jurkat, glial, and neuronal cells. J Virol 1995;69:6634-42
11. + T-cell levels. AIDS 1993;7:1159-66
12. Buchbinder SP, Katz MH, Hessol NA, et al. Long-term HIV-1 infection without immunologic progression. AIDS 1994;8:1123-8
13. Greenough TC, Somasundaran M, Brettler DB, et al. Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection. AIDS Res Hum Retrovir 1994;10:395-403
14. Cao Y, Qin L, Zhang L, et al. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995;332:201-8
15. Panyaleo G, Menzo S, Vaccarezza M, et al. Studies in subjects with long-term non-progressive human immunodeficiency virus infection. N Engl J Med 1995;332:209-16
16. Jassoy C, Harrer T, Rosenthal T, et al. Human immunodeficiency virus type 1-specific cytotoxic T-lymphocytes release gamma Interferon, tumor necrosis factor alpha(TNF-alpha), and TNF-beta when they encounter their target antigens. J Virol 1993;67:2944-52
17. + cell antiviral factor. Cell Immunol 1994;153:329-43
18. + T-cells. Science 1995;270:1811-15
19. Baier M, Werner A, Bannert N, et al. HIV suppression by interleukin-16. Nature 1995;378:563